The Chinese medicinal herbal formula ZYD88 inhibits cell growth and promotes cell apoptosis in prostatic tumor cells

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1633-1639

  Zhu, Yuan Shan ^a   Huang, Ying ^a   Cai, Li Qun ^a   Zhu, Jeff ^a   Duan, Quwen ^b   Duan, Yanwen ^b   Imperato McGinley, Julianne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Changsha Cihang Research Institute of Materia Medica   (China)

Author keywords

Apoptosis; Caspase 3; Cell growth; Herb; Prostate cancer

Indexed keywords

CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; DNA FRAGMENT; HERBACEOUS AGENT; ZYD88 CPD;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; MALE; PROSTATE TUMOR; TIME; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; MALE; PROSTATIC NEOPLASMS; TIME FACTORS; TRANSFECTION;

EID: 2142798555     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1633     Document Type: Article

References (31)

1. Carter HB and Coffey DS: The prostate: an increasing medical problem. Prostate 16: 39-48, 1990. (Pubitemid 20127957)
2. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L and Edwards BK: SEER cancer statistics review, 1973-1997. National Cancer Institute, Bethesda, MD, 2000.
3. Jemal A, Tomas A, Murray T and Thun M: Cancer Statistics 2002. CA Cancer J Clin 52: 23-47, 2002.
4. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS and Isaacs IT: Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25: 249-265, 1994. (Pubitemid 24364130)
5. Raghavan D, Koczwara B and Javle M: Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33: 566-574, 1997. (Pubitemid 27223739)
6. Dowling AJ and Tannock IF: Systemic treatment for prostate cancer. Cancer Treat Rev 24: 283-301, 1998. (Pubitemid 28488282)
7. Algan O, Stobbe CC, Helt AM, Hanks GE and Chapman JD: Radiation inactivation of human prostate cancer cells: the role of apoptosis. Radiat Res 146: 267-275, 1996. (Pubitemid 26320090)
8. Fournier G: Treatment of hormone-refractory prostate carcinoma. Eur Urol (Suppl. 1) 30: 32-37, 1996.
9. Medini E, Medini I, Reddy PK and Levitt SH: Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy, a long term follow-up. Cancer 78: 1254-1259, 1996. (Pubitemid 26303892)
10. Zhao XY, Peehl DM, Navone NM and Feldman D: 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Endocrinology 141: 2548-2556, 2000. (Pubitemid 32269075)
11. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S and Cohen J: Antisense-mediated inhibition of bcl2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 50: 6565-6570, 1990. (Pubitemid 20348780)
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
13. Zhu YS, Yen PM, Chin WW and Pfaff DW: Estrogen and thyroid hormone interaction on regulation of gene expression. Proc Natl Acad Sci USA 93: 12587-12592, 1996. (Pubitemid 26367188)
14. Kumi-Diaka J, Sanderson NA and Hall A: The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU 145 and LNCaP. Biol Cell 92: 595-604, 2000. (Pubitemid 32366627)
15. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN and Gallo MA: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339: 785-791, 1998. (Pubitemid 28447451)
16. Chen S: In vitro mechanism of PC SPES. Urology (Suppl. 2A) 58: 28-35, 2001.
17. Knowles LM, Zigrossi DA, Tauber RA, Hightower C and Milner JA: Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 38: 116-122, 2000. (Pubitemid 32377951)
18. Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, Lambert G and DiPaola RS: Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 20: 2653-2658, 2000. (Pubitemid 30614480)
19. Darzynkiewicz Z, Carter SP, Kapuscinski J and Watanabe KA: Effect of derivatives of chrysophanol, a new type of potential antitumor agents of anthraquinone family, on growth and cell cycle of L1210 leukemic cells. Cancer Lett 46: 181-187, 1989. (Pubitemid 19219211)
20. Koyama M, Takahashi K, Chou TC, Darzynkiewicz Z, Kapuscinski J, Kelly TR and Watanabe KA: Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2. Derivatives of chrysophanol and emodin. J Med Chem 32: 1594-1599, 1989. (Pubitemid 19205371)
21. Chen CH, Chao YC and Li DD: Studies of Chinese rhubarb, IX: the effect of rhein and emodin on transplantable tumors in animals. Yao Xue Xue Bao 13: 363-366, 1966.
22. Shi YQ, Fukai T, Sakagami H, Kuroda J, Miyaoka R, Tamura M, Yoshida N and Nomura T: Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb. Anticancer Res 21: 2847-2853, 2001. (Pubitemid 33054466)
23. Lee HZ: Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. Br J Pharmacol 134: 11-20, 2001.
24. Lee HZ, Hsu SL, Liu MC and Wu CH: Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 431: 287-295, 2001. (Pubitemid 33145405)
25. Ohnishi S, Fukamiya N, Okano M, Tagahara K and Lee KH: Bruceosides D, E, and F, three new cytotoxic quassinoid glucosides from Brucea javanlca. J Nat Prod 58: 1032-1038, 1995.
26. Su SY: Treatment of lung cancer with brain metastasis using an intravenous drip of a 10% emulsion of Brucea javanica seminal oil. Zhong Xi Yi Jie He Za Zhi 5: 86-87, 1985.
27. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, Newmark H, Steele VE, Kelloff GJ and Lipkin M: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21: 1655-1660, 2000.
28. Kurzer MS and Xu X: Dietary phytoestrogens. Annu Rev Nutr 17: 353-381, 1997. (Pubitemid 27328805)
29. Peterson G and Barnes S: Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22: 335-345, 1993. (Pubitemid 23176275)
30. Pollard M, Wolter W and Sun L: Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. In Vivo 14: 389-392, 2000. (Pubitemid 30433364)
31. Adlercreutz H: Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 12: 605-623, 1998.